- Home
- Life Sciences
- Plasma Fractionation
Plasma Fractionation Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.
-
Published date -30th Jan 2024
-
Formats -PDF, CSV
-
Region -Global
1. Market Size & CAGR of Plasma Fractionation Market in 2021
The global plasma fractionation market is expected to reach a market size of USD 23.5 billion by the end of 2021 with a compound annual growth rate (CAGR) of 6.8% during the forecast period.
2. COVID-19 Impact on the Plasma Fractionation Market
The COVID-19 pandemic has significantly impacted the plasma fractionation market. The market witnessed a surge in demand for plasma-derived products, especially for the treatment of COVID-19 patients. The disruptions in the supply chain and restrictions on plasma donation have also affected the market dynamics.
3. Plasma Fractionation Dynamics
The plasma fractionation market is driven by the increasing prevalence of chronic diseases, rising geriatric population, and advancements in plasma collection and processing technologies. However, factors such as stringent regulations and high production costs may hinder market growth.
4. Segments and Related Analysis
The plasma fractionation market is segmented based on product type, application, end-user, and region. The key segments include immunoglobulins, albumin, coagulation factors, and others. Each segment caters to specific medical needs and has a significant impact on the overall market dynamics.
5. By Region Analysis
The plasma fractionation market is analyzed across regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominates the market due to the presence of key market players and a well-established healthcare infrastructure. However, the Asia Pacific region is expected to witness significant growth during the forecast period.
6. Key Market Players and Competitive Landscape
Key market players in the plasma fractionation market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest AG. These players focus on strategic collaborations, product launches, and acquisitions to strengthen their market presence. The market is highly competitive with increasing investments in research and development activities.
7. Recent Happenings in the Plasma Fractionation Market
In recent developments, CSL Behring announced the launch of a new plasma-derived therapy for the treatment of autoimmune disorders. Grifols acquired a leading plasma collection company to expand its plasma collection network. These developments highlight the evolving landscape of the plasma fractionation market and the growing focus on innovative therapies.
